Historically, joint venture transactions were driven by commercial reimbursement, management expertise, cost efficiencies, and access to capital. While these drivers are still prevalent today new motivators continue to emerge including changing reimbursement models, access to network and infrastructure, and payor pressures to put patients in the lowest cost setting. The post-acute segment is in a strong position to benefit from these transaction drivers and health systems have participated in a flurry of joint ventures with specialty management companies. This presentation will explore the market and business rational of joint ventures along with an in-depth view of a health systems recent experience.
1. The audience will gain an understanding of current market overview and dynamics driving post-acute joint ventures
2. Understand the benefits and risks when entering a joint venture
3. Discuss operational and structural considerations when forming a joint venture
4. Participate in a case study of CHRISTUS’ recent joint venture with LHC Group including a review of preliminary indicators of success